GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Ranson's Criteria
Pancreas & Biliary

Ranson's Criteria

Acute pancreatitis severity at 48 hours

Aetiology

Gallstone pancreatitis uses a modified set of thresholds and omits the PaO₂ criterion, giving 10 criteria instead of 11.

On admission

Scored from the first values available after presentation.

The same threshold applies in both aetiologies.

Within 48 hours

Scored from the change over the first 48 hours. The score is incomplete before this point.

A fall despite fluid resuscitation, reflecting third-space loss and haemorrhage.

Included only in the non-gallstone criteria — the gallstone variant omits it.

The admission criteria can be scored on arrival, but the score is not complete — and should not be quoted — until 48 hours have passed. Use BISAP if you need a severity estimate on day one.

When to use
Score it at the 48-hour mark, once the trajectory of the first two days is visible, to confirm or revise the severity assessment you made on admission. That is the window it was designed for and the only one in which it is complete. It has a second, narrower use: because it is scored on the worst values across 48 hours rather than a snapshot, it captures deterioration that a single-timepoint score misses, so a patient who looked well on arrival and has quietly accumulated criteria will be flagged. Do not use it to make the day-one triage decision — nothing about Ranson's criteria is available in time for that, and BISAP exists for exactly that gap. Choose the criteria set before you start: gallstone and non-gallstone pancreatitis do not share thresholds.
Why use it
Because it misses fewer severe cases than anything newer. The push toward simpler scores has been driven by convenience rather than accuracy, and Ranson has quietly held up: in a prospective cohort of 185 patients it discriminated severe acute pancreatitis with an AUC of 0.94, ahead of CTSI at 0.84, BISAP at 0.81 and APACHE II at 0.78. A 2024 meta-analysis of 5,476 patients put its pooled sensitivity for severity at 0.95 against BISAP's 0.67. If the question is 'could this patient still turn out to be severe', a Ranson score of 0–2 at 48 hours is the most reassuring number available at the bedside. The cost is the 48-hour wait and the eleven data points, and that cost is real — but it buys sensitivity that the one-day scores do not have.
Formula, evidence and interpretation

About the Ranson's Criteria for Acute Pancreatitis Severity

Ranson's criteria count adverse prognostic signs in acute pancreatitis — 11 of them in non-gallstone disease, and a modified set of 10 in gallstone pancreatitis that uses different thresholds and drops the PaO₂ criterion. Four or five are read on admission and the rest from the change over the first 48 hours, which is why the score cannot honestly be quoted before then. Two or fewer criteria carries mortality of roughly 0–3%; three to four around 15%; five to six around 40%; and seven or more approached 100% in the original series. Its strength is sensitivity — pooled across 15 studies it detected 95% of severe cases, more than any competing bedside score.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Ranson score = number of criteria met (each 1 point) — max 11 non-gallstone, max 10 gallstone
On admission (both sets)
Age, white cell count, glucose, LDH, AST. Five signs, all from the first values after presentation.
Within 48 hours (both sets)
Calcium fall, haematocrit fall, BUN rise, base deficit, fluid sequestration. Five signs, all requiring the trend rather than a single value.
Within 48 hours (non-gallstone only)
PaO₂ below 60 mmHg — the eleventh criterion.
  • Each criterion is worth exactly one point. There is no weighting, so a base deficit and an age over 55 contribute equally — a known crudeness of the score rather than an implementation choice.
  • The score is not valid before 48 hours. Five or six of the criteria are defined as changes over that window and simply cannot be evaluated earlier; a 'Ranson score' quoted on admission is at most a partial count.
  • Pick the criteria set from the aetiology before scoring. Applying non-gallstone thresholds to gallstone pancreatitis will over-score age and under-score the urea rise.
  • Fluid sequestration is intake minus output cumulated over the 48 hours, not an estimate of oedema.
  • Once scored, the score is not repeated. Ranson's criteria describe the first 48 hours and were never designed as a serial monitoring tool.

Interpreting the result

Read the number against the band table, but read the timing first: a score derived from fewer than 48 hours of data is not a Ranson score and should not be recorded as one. At 0–2 criteria the patient is very unlikely to have severe disease — this is the score's strongest statement, resting on a pooled sensitivity of 0.95, and it is the point at which stepping down from high-dependency care becomes reasonable. From three criteria upward the number is better treated as a gradient of concern than as a set of discrete categories; the jump from 15% to 40% mortality across the 3–4 and 5–6 bands is derived from small numbers in the original cohort and the confidence intervals around those figures are wide. Two cautions on the high end. The near-100% mortality at seven or more comes from a 1974 series and predates modern intensive care, enteral feeding and the shift away from early necrosectomy; contemporary outcomes are better, and the figure should be used to convey gravity rather than quoted to a family as a probability. And a low score never excludes local complications — necrosis, walled-off collections and pseudocysts develop on their own timescale, which is what CTSI is for.

ScoreBandWhat it meansAction
0–2Low riskMortality approximately 0–3%Ward-level care: fluids, analgesia, early enteral feeding. Reasonable point to step down from high-dependency care
3–4Moderate riskMortality approximately 15%High-dependency care; monitor actively for organ dysfunction rather than waiting for it to declare
5–6High riskMortality approximately 40%Intensive care assessment, aggressive supportive management, CT at around 72 hours to grade necrosis
≥ 7Very high riskMortality approached 100% in the 1974 series; materially better with modern critical careIntensive care, and an honest conversation about prognosis with the patient and family

What the Ranson's Criteria needs (12 inputs)

Aetiology — gallstone or non-gallstone
Chosen first, because it changes almost every threshold. The non-gallstone set is the original 1974 criteria; the gallstone set comes from Ranson's 1979 biliary-surgery timing paper and uses higher cut-offs for age, white cell count, glucose and LDH, lower cut-offs for the urea rise and fluid sequestration, and omits PaO₂ altogether.
Age — over 55 (non-gallstone) or over 70 (gallstone)
Admission criterion. The gallstone threshold is higher because that population is older overall, so 55 would flag nearly everyone and discriminate nothing.
White cell count — over 16,000/mm³ (non-gallstone) or over 18,000/mm³ (gallstone)
Admission criterion, reflecting the systemic inflammatory response rather than infection. A high count in the first 48 hours of pancreatitis is not a reason to start antibiotics.
Blood glucose — over 200 mg/dL (11 mmol/L) non-gallstone, over 220 mg/dL (12.2 mmol/L) gallstone
Admission criterion. Reflects loss of islet function in an inflamed gland, so it means less in a patient with established diabetes — a limitation the criteria never addressed.
Serum LDH — over 350 IU/L (non-gallstone) or over 400 IU/L (gallstone)
Admission criterion, a marker of tissue necrosis. Note that laboratory LDH reference ranges have shifted with assay changes since 1974, which is worth checking against your own local range.
Serum AST — over 250 IU/L
Admission criterion, and the one threshold identical in both sets. Written as SGOT in the original papers.
Serum calcium — below 8.0 mg/dL (2.0 mmol/L)
48-hour criterion, shared by both sets. Hypocalcaemia here is a consequence of calcium being consumed in the saponification of retroperitoneal fat, so it is a direct signal of necrosis rather than an incidental electrolyte result.
Haematocrit fall — more than 10%
48-hour criterion, shared. A fall despite resuscitation, reflecting third-space loss and haemorrhage into the retroperitoneum. Note the direction: it is the drop that scores, so a persistently high haematocrit from haemoconcentration does not.
BUN rise despite IV fluids — 5 mg/dL or more (non-gallstone), 2 mg/dL or more (gallstone)
48-hour criterion. 'Despite fluids' is the substance of it — a urea that rises while the patient is being resuscitated indicates that resuscitation is failing, which is a different statement from a raised urea on arrival.
Base deficit — greater than 4 mEq/L (non-gallstone) or greater than 5 mEq/L (gallstone)
48-hour criterion, from an arterial or venous gas. A marker of tissue hypoperfusion.
Fluid sequestration — greater than 6 L (non-gallstone) or greater than 4 L (gallstone)
48-hour criterion, calculated as cumulative intake minus output over the 48 hours. The single hardest criterion to score reliably, because it depends on fluid-balance charting that is frequently incomplete.
Arterial PaO₂ — below 60 mmHg (non-gallstone only)
48-hour criterion in the original set, and absent from the gallstone set. This is why the maximum is 11 in one variant and 10 in the other, and it is the most common source of confusion about how many Ranson criteria there are.

Units. The criteria are written in US conventional units, which is why the thresholds look unfamiliar outside North America. Glucose 200 mg/dL is 11.1 mmol/L and 220 mg/dL is 12.2 mmol/L; calcium 8.0 mg/dL is 2.0 mmol/L. BUN and urea are not interchangeable — a BUN in mg/dL multiplied by 2.14 gives urea in mg/dL, and BUN mg/dL divided by 2.8 gives urea in mmol/L, so a BUN rise of 5 mg/dL corresponds to a urea rise of about 1.8 mmol/L. PaO₂ 60 mmHg is 8.0 kPa. LDH and AST thresholds are assay-dependent and the 1974 reference ranges are not those of a modern laboratory, so compare against your local range rather than assuming the printed cut-off transfers.

What it returns

Number of criteria met
0 to 11 in non-gallstone pancreatitis, 0 to 10 in gallstone pancreatitis. Unweighted — every criterion counts one, and the score makes no attempt to rank them by importance.
Risk band and associated mortality
Four bands, from low risk at 0–2 to very high risk at 7 or more. The percentages are those reported in the original series and its early validations.
Which criteria set was applied
Surfaced explicitly, because a score of 4 means something different depending on which of the two threshold sets produced it, and the two are frequently conflated in case notes.

How it is calculated

Ranson and colleagues took 100 patients with acute pancreatitis, examined 43 candidate clinical and laboratory signs, and kept the 11 that separated survivors from non-survivors and uncomplicated from complicated courses. That method explains both the score's virtues and its oddities. The signs are a mix of inflammatory load, end-organ perfusion and evidence of necrosis, which is why they capture severity broadly rather than through a single mechanism — and it is why the score is unweighted, since it was selected for discrimination rather than fitted as a regression. The split between admission and 48-hour criteria is not an inconvenience of the design; it is the design. Roughly half the criteria are defined as a trajectory, on the reasoning that acute pancreatitis declares its severity over two days rather than on arrival, and a score that reads the trajectory will outperform one that reads a snapshot. The 1979 modification arose because that logic did not transfer to gallstone pancreatitis, where the population is older and the physiology of a transient obstructive insult differs enough that the original thresholds mis-scored it.

Facts & figures

The two criteria sets side by side
CriterionNon-gallstoneGallstone (modified)
Age> 55 years> 70 years
White cell count> 16,000/mm³> 18,000/mm³
Glucose> 200 mg/dL (11 mmol/L)> 220 mg/dL (12.2 mmol/L)
LDH> 350 IU/L> 400 IU/L
AST> 250 IU/L> 250 IU/L
Calcium fall< 8.0 mg/dL (2.0 mmol/L)< 8.0 mg/dL (2.0 mmol/L)
Haematocrit fall> 10%> 10%
BUN rise despite fluids≥ 5 mg/dL≥ 2 mg/dL
Base deficit> 4 mEq/L> 5 mEq/L
Fluid sequestration> 6 L> 4 L
PaO₂< 60 mmHgNot included
Maximum score1110

AST is the only threshold shared exactly. The absent PaO₂ criterion is what makes the gallstone maximum 10, and it is the usual reason two clinicians disagree about how many Ranson criteria exist.

Head-to-head accuracy for predicting severe acute pancreatitis (185 patients, Papachristou 2010)
ScoreAUC (95% CI)Data window
Ranson's criteria0.94 (0.89–0.97)48 hours
CTSI0.84 (0.76–0.89)Contrast CT, usually ≥ 72 hours
BISAP0.81 (0.74–0.87)24 hours
APACHE II0.78 (0.71–0.84)24 hours

In this cohort of 185 patients — 22% severe, 19% with necrosis, 3.8% mortality — Ranson was the most accurate of the four. The authors' own conclusion was that the simple scores have reached their ceiling and new models are needed, not that any one of these should replace the others.

Ranson vs BISAP, pooled (meta-analysis of 15 studies in quantitative analysis)
Outcome and metricRansonBISAP
Severity — sensitivity0.95 (0.87–0.98)0.67 (0.27–0.92)
Severity — specificity0.74 (0.52–0.88)0.95 (0.85–0.98)
Mortality — sensitivity0.89 (0.73–0.96)0.77 (0.58–0.89)
Mortality — specificity0.79 (0.68–0.87)0.90 (0.86–0.93)

A clean trade-off across 5,476 patients: Ranson is the sensitive test and BISAP the specific one. Overall accuracy is comparable, so the choice between them is decided by what you need — ruling severity out, or avoiding false alarms — and by when you need it.

Evidence

Derivation — Ranson et al., New York, 1974

1974 · n = 100

100 patients with acute pancreatitis at New York University, in whom 43 candidate prognostic signs were assessed and the 11 that best separated survivors from non-survivors and uncomplicated from complicated courses were retained. Published in Surgical Gynecology and Obstetrics alongside an argument about the role of operative management, which was the live surgical controversy of the period.

Mortality rose steeply with the number of signs present — approximately 0–3% at two or fewer, around 15% at three to four, around 40% at five to six, and approaching 100% at seven or more.

Modified gallstone criteria — Ranson, 1979

1979

Ranson's analysis of the timing of biliary surgery in acute pancreatitis, in which the thresholds were re-derived for gallstone disease. This is the source of the 10-criterion modified set, with its higher age, white cell, glucose and LDH cut-offs, lower urea-rise and fluid-sequestration thresholds, and no PaO₂ criterion.

Established that the original thresholds mis-classified gallstone pancreatitis, whose population is older and whose insult is often a transient obstruction rather than a primary parenchymal injury.

Head-to-head prospective comparison — Papachristou et al., Pittsburgh

2010 · n = 185

185 consecutive patients with acute pancreatitis admitted or transferred to a single centre between June 2003 and September 2007, 73% of whom had contrast-enhanced CT. 40 developed organ failure (22%), 36 developed pancreatic necrosis (19%), and 7 died (3.8%).

AUC for predicting severe acute pancreatitis: Ranson 0.94 (0.89–0.97), CTSI 0.84 (0.76–0.89), BISAP 0.81 (0.74–0.87), APACHE II 0.78 (0.71–0.84). Ranson was the most accurate of the four in this cohort.

Systematic review and meta-analysis vs BISAP, 2024

2024 · n = 5,476

17 studies comprising 5,476 patients with acute pancreatitis, 15 entering the quantitative synthesis, comparing Ranson and BISAP for both severity and mortality.

Ranson pooled sensitivity 0.95 (0.87–0.98) and specificity 0.74 (0.52–0.88) for severity, versus BISAP 0.67 (0.27–0.92) and 0.95 (0.85–0.98). For mortality, Ranson 0.89 (0.73–0.96) and 0.79 (0.68–0.87), BISAP 0.77 (0.58–0.89) and 0.90 (0.86–0.93). Overall performance comparable; Ranson consistently the more sensitive.

Ceiling of the existing scores — Mounzer et al.

2012 · n = 653

Two prospective cohorts, 256 patients for training and 397 for validation, in which nine clinical scores were calculated on admission and again at 48 hours and compared for prediction of persistent organ failure.

Existing scores achieved AUCs of 0.62–0.84 at admission in training and 0.57–0.74 in validation. Combining scores into 12 predictive rules raised accuracy to 0.92 and 0.84 but was judged too cumbersome for clinical use. The authors concluded the simple scoring systems have reached their maximal efficacy.

How it compares

Ranson's Criteria vs BISAP

BISAP is the only one of the two available when the triage decision is made; Ranson is the more sensitive once 48 hours have passed, so the sequence is BISAP on day one and Ranson to confirm at 48 hours — not a choice between them.

The trade-off is consistent across the literature. Pooled over 5,476 patients, Ranson's sensitivity for severity was 0.95 against BISAP's 0.67, while BISAP's specificity was 0.95 against Ranson's 0.74; the same pattern held for mortality. So Ranson misses fewer severe cases and BISAP raises fewer false alarms, at comparable overall accuracy. In a single prospective cohort of 185 patients Ranson also had the higher AUC for severe disease, 0.94 against 0.81. None of that helps at hour six, when the patient needs a bed — and that is the whole argument for BISAP's existence.

Open the BISAP calculator →Predictive value of the Ranson and BISAP scoring systems for the severity and prognosis of acute pancreatitis: a systematic review and meta-analysis. PLoS One. 2024;19(4):e0302046.

Ranson's Criteria vs Glasgow-Imrie criteria

Glasgow-Imrie asks for eight variables instead of eleven and reaches a comparable answer, which is why it displaced Ranson in UK practice — but it was derived to be completed at 48 hours too, so it solves the data burden rather than the timing problem.

Blamey and Imrie's Glasgow group set out explicitly to simplify Ranson: they tested the original criteria in a British population, found several contributed little, and produced an eight-factor set that omits the haematocrit fall, the base deficit and fluid sequestration — the three that are most laborious or least reliably recorded. Head to head, in two prospective cohorts totalling 653 patients, the Glasgow score was the best classifier at admission of the nine scores tested. Both scores are read at 48 hours and both use three-or-more as a severity threshold in most practice, so in most units the choice is regional habit rather than evidence.

Open the Glasgow-Imrie criteria calculator →Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142(7):1476-1482.

Ranson's Criteria vs CT severity index

They measure different things and neither substitutes for the other — Ranson grades the physiological insult over 48 hours, CTSI grades the anatomical damage on imaging, and a patient can score badly on one and well on the other.

CTSI combines Balthazar's inflammation grade with the extent of necrosis, so it answers 'what does the gland look like' and predicts local complications and the need for intervention. Ranson answers 'how hard is this hitting the patient'. Timing separates them further: Ranson is complete at 48 hours, while CT under-stages necrosis before around 72 hours, so imaging too early produces a falsely reassuring CTSI. In the Pittsburgh comparison Ranson had the higher AUC for severe disease, 0.94 against 0.84 — but that is a comparison on Ranson's own outcome, and it does not mean CTSI is redundant. Use Ranson to decide the level of care and CTSI to decide whether anything needs draining.

Open the CT severity index calculator →Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010;105(2):435-441.

Ranson's Criteria vs APACHE II

APACHE II can be scored on day one and repeated daily, which Ranson cannot, but it needs a dozen variables and was built for general intensive care — in acute pancreatitis specifically it has not outperformed Ranson.

In the 185-patient prospective comparison APACHE II had the lowest AUC of the four scores tested for severe acute pancreatitis, 0.78 against Ranson's 0.94, despite requiring considerably more data. Its advantages are real but different: it is not disease-specific, so it works in a mixed intensive care population, and it can be recalculated each day to track a trajectory. In a patient already in intensive care where APACHE II is being scored anyway, there is little reason to add Ranson; on a general ward the arithmetic is impractical and a dedicated pancreatitis score is the better tool.

Pearls & pitfalls

  • There is no such thing as an admission Ranson score. Five or six criteria are defined as changes over 48 hours, so a number quoted on day one is a partial count and will systematically understate severity.
  • Choose the criteria set from the aetiology first. Scoring gallstone pancreatitis with non-gallstone thresholds is the commonest error, and it pushes the score in both directions at once — over-scoring on age, under-scoring on the urea rise.
  • The gallstone set has 10 criteria, not 11, because it omits PaO₂. Most disagreements about 'how many Ranson criteria there are' come from this.
  • It is the haematocrit fall that scores, not a high haematocrit. Haemoconcentration on admission is a separate prognostic sign and is not part of this score.
  • 'BUN rise despite IV fluids' means what it says. A urea already raised on arrival that then settles with resuscitation does not meet the criterion.
  • Fluid sequestration is the weakest link in practice — it requires 48 hours of accurate fluid-balance charting, and where the chart is incomplete the criterion is usually silently scored as absent.
  • The glucose criterion loses meaning in established diabetes, and the criteria offer no adjustment for it.
  • Do not re-score it serially. Ranson's criteria characterise the first 48 hours; there is no validated way to repeat them on day five.
  • The near-100% mortality at seven or more criteria is a 1974 figure from a small series. Use it to convey seriousness, not as a number to give a family.
  • A low score says little about local complications. Necrosis and collections follow their own timeline and need CT, not a clinical score.

Critical actions

  • Confirm the aetiology before scoring, and record which criteria set you used alongside the number.
  • Do not wait for the score to start treatment. Fluid resuscitation, analgesia and early enteral feeding are driven by the clinical picture from the first hour, and a score completed at 48 hours cannot inform them.
  • Use BISAP or a SIRS assessment for the day-one triage decision, then let Ranson confirm or revise it at 48 hours.
  • In gallstone pancreatitis, arrange biliary imaging, and urgent ERCP if there is coexisting cholangitis. Then plan cholecystectomy — same-admission surgery in mild disease is what prevents recurrence.
  • At three or more criteria, escalate the level of care before organ dysfunction is established rather than after.
  • Image at around 72 hours, or sooner if the patient deteriorates, and grade any necrosis with CTSI. Earlier CT under-stages necrosis.
  • Do not drain sterile necrosis because of how it looks on a scan. Intervention is driven by clinical deterioration and infection, and delayed, minimally invasive approaches outperform early necrosectomy.
  • Reassess clinically regardless of the score. Both a reassuring and an alarming Ranson score describe the first 48 hours only.

Why this score exists

The 1974 paper was not written to give the world a severity score. Its subject was whether patients with acute pancreatitis should be operated on, and at that time early laparotomy was a serious proposition; the prognostic signs were assembled to identify which patients were sick enough that the question arose. That origin explains a feature of the criteria that looks strange now — they are weighted toward things a surgeon could act on, and they are scored across 48 hours because that was the period over which the operative decision was made. Ranson returned to the criteria in 1979 for the same reason, asking when biliary surgery should be performed in gallstone pancreatitis, and re-derived the thresholds because the original set did not fit that population. The score outlived the controversy that produced it, which is worth knowing when judging it: it has held its accuracy for fifty years while the management question it was built to answer has been settled in the opposite direction, toward avoiding early operation entirely.

About the creator

  • John H. C. Ranson

    First author, 1974 and 1979 papers; Department of Surgery, New York University

    Led the 1974 analysis of 43 prognostic signs that produced the original 11 criteria, and the 1979 re-derivation of thresholds for gallstone pancreatitis.

  • Kenneth M. Rifkind

    Co-author, 1974 derivation paper

    Co-authored the original derivation of the prognostic signs.

  • Daniel F. Roses

    Co-author, 1974 derivation paper

    Co-authored the original derivation of the prognostic signs.

Limitations

  • Not complete until 48 hours, which excludes it from the decision it would be most useful for — where to put the patient on arrival.
  • Derived from 100 patients in one New York hospital in 1974, before contemporary intensive care, enteral nutrition, and the move away from early necrosectomy. The mortality figures in the upper bands are correspondingly dated.
  • Unweighted. Age over 55 and a base deficit above 4 mEq/L each score one point, which does not reflect their relative prognostic force.
  • Specificity is only moderate — pooled at 0.74 for severity — so a raised score generates a meaningful number of false alarms.
  • Fluid sequestration and the haematocrit fall depend on the quality of fluid-balance and serial-bloods documentation, and are frequently under-recorded rather than genuinely absent.
  • Two threshold sets invite scoring error, and the literature is inconsistent about which is meant when 'Ranson's criteria' is cited without qualification.
  • The glucose criterion is confounded by pre-existing diabetes and the LDH threshold by assay drift since 1974.
  • It predicts severity and mortality, not local complications, and says nothing about the need for intervention.
  • Not validated for serial use, in children, or in pregnancy.
  • Like every score in this field, its accuracy appears to have plateaued — the 2012 analysis concluded the existing systems have reached their maximal efficacy and that better prediction will require a different approach, not a better checklist.

If you are the patient

Ranson's criteria are a list of eleven warning signs that doctors look for in the first two days after someone is admitted with pancreatitis. They come from blood tests, your age, how much oxygen is in your blood, and how your body responds to the fluids given through a drip. Each sign that is present counts as one point. The reason the doctors wait two days before adding it up is that pancreatitis often shows how serious it is going to be over time rather than straight away, so the two-day picture is more reliable than the first few hours. A low score — two or fewer — is genuinely reassuring and usually means treatment on a normal ward. A higher score means you will be watched more closely, often in a high-dependency or intensive care unit, and it prompts the team to look for complications sooner. It is worth knowing that the frightening survival figures sometimes quoted for high scores come from the 1970s, and outcomes today are considerably better because intensive care and the treatment of pancreatitis have both changed a great deal. If your pancreatitis was caused by gallstones, a slightly different version of the list is used, and you will usually be offered surgery to remove your gallbladder to stop it happening again.

Frequently asked questions

How many Ranson criteria are there — 10 or 11?#

Both, depending on the aetiology. Non-gallstone pancreatitis uses the original 11 criteria. Gallstone pancreatitis uses a modified set of 10, which applies different thresholds for age, white cell count, glucose, LDH, the urea rise and fluid sequestration, and omits the PaO₂ criterion entirely. That omission is the reason the two totals differ.

Why can't Ranson's score be calculated on admission?#

Because five or six of the criteria are defined as changes over the first 48 hours — the haematocrit fall, the urea rise despite fluids, fluid sequestration, the calcium fall, the base deficit and, in non-gallstone disease, the PaO₂. Only the age, white cell count, glucose, LDH and AST criteria can be read on arrival. A number quoted on day one is a partial count and will understate severity, which is why BISAP exists for the first 24 hours.

What Ranson score is considered severe?#

Three or more criteria is the usual threshold for predicting a severe course. Mortality is roughly 0–3% at two or fewer, around 15% at three to four, around 40% at five to six, and approached 100% at seven or more in the original 1974 series — although that upper figure predates modern intensive care and contemporary outcomes are considerably better.

Is Ranson or BISAP better for acute pancreatitis?#

Neither is simply better; they trade sensitivity against specificity. Pooled across 5,476 patients, Ranson detected 95% of severe cases against BISAP's 67%, while BISAP was the more specific at 95% against 74%. The decisive practical difference is timing — BISAP is complete at 24 hours and Ranson is not complete until 48 — so the sensible approach is BISAP for the initial triage and Ranson to confirm or revise at 48 hours.

What is the difference between Ranson's and the Glasgow-Imrie criteria?#

Glasgow-Imrie is a deliberate simplification of Ranson derived in a British population: eight factors instead of eleven, dropping the haematocrit fall, base deficit and fluid sequestration, which are the most laborious to obtain. Both are read at 48 hours and both use three or more criteria as the severity threshold, and head-to-head performance is comparable. In practice the choice is regional convention rather than evidence.

Which criteria set do I use for gallstone pancreatitis?#

The modified 10-criterion set from Ranson's 1979 paper. It raises the age threshold to 70, the white cell count to 18,000/mm³, glucose to 220 mg/dL and LDH to 400 IU/L; it lowers the qualifying urea rise to 2 mg/dL and fluid sequestration to 4 L; and it drops PaO₂. Applying the non-gallstone thresholds instead is the most common scoring error with this score.

Can Ranson's score be repeated later in the admission?#

No. It was derived to characterise the first 48 hours and has never been validated as a serial measure. If you need to track a trajectory beyond that window, a general physiological score such as APACHE II can be recalculated daily, and deterioration should prompt imaging rather than re-scoring.

Does a low Ranson score mean there are no complications?#

No. The score predicts severity and mortality, not local complications. Necrosis, walled-off collections and pseudocysts develop on their own timescale and are graded on contrast CT — usually at around 72 hours, since imaging earlier under-stages necrosis. CTSI is the tool for that question.

How accurate is Ranson's score compared with APACHE II?#

In a prospective cohort of 185 patients, Ranson discriminated severe acute pancreatitis with an AUC of 0.94, ahead of CTSI at 0.84, BISAP at 0.81 and APACHE II at 0.78 — so despite requiring far more variables, APACHE II performed least well of the four for this specific outcome. APACHE II's advantages are that it is available on day one and can be repeated daily, not that it is more accurate in pancreatitis.

Related calculators

  • HAPS — Harmless acute pancreatitis score
  • BISAP Score — Bedside index for severity of pancreatitis
  • Glasgow-Imrie Criteria — Acute pancreatitis severity — the PANCREAS criteria
  • CTSI — CT severity index — pancreatitis
  • Revised Atlanta Classification — Acute pancreatitis severity — mild, moderately severe, severe
  • Biliary Pain (Rome IV) — Rome IV — defining biliary-type pain before intervention

References

Original / primary reference

  1. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139(1):69-81.
  2. Ranson JH. The timing of biliary surgery in acute pancreatitis. Ann Surg. 1979;189(5):654-663 (source of the modified gallstone criteria).

Validation and evidence

  1. Papachristou GI, Muddana V, Yadav D, O'Connell M, Sanders MK, Slivka A, Whitcomb DC. Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol. 2010;105(2):435-441.
  2. Predictive value of the Ranson and BISAP scoring systems for the severity and prognosis of acute pancreatitis: a systematic review and meta-analysis. PLoS One. 2024;19(4):e0302046.
  3. Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, Singh VK, Slivka A, Whitcomb DC, Yadav D, Banks PA, Papachristou GI. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142(7):1476-1482.

Clinical practice guidelines

  1. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-1415.
  2. Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154(4):1096-1101.
  3. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1-e15.

Other references

  1. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111.

Last updated July 30, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.